ACT-389949 is a first-in-class, potent and selective and agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes. ACT-389949 has potential for the treatment of inflammatory disorders[1][2].
Molecular Weight:
428.39
Purity:
99.96
CAS Number:
[1258417-54-7]
Formula:
C20H18F2N6O3
Target:
Formyl Peptide Receptor (FPR)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted